Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication

Journal of Viral Hepatitis

Volumn 13, Issue 9, 2006, Pages 582-590

  Kohashi, T ^a   Maekawa, S ^a,b   Sakamoto, N ^a   Kurosaki, M ^a   Watanabe, H ^a   Tanabe, Y ^a   Chen, C H ^a   Kanazawa, N ^a   Nakagawa, M ^a   Kakinuma, S ^a   Yamashiro, T ^a   Itsui, Y ^a   Koyama, T ^a   Enomoto, N ^b   Watanabe, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

HCV replicon; ISDR; NS5A

Indexed keywords

AMINO ACID; INTERFERON;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CODON; COLONY FORMATION; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERFERON SENSITIVITY DETERMINING REGION; MAJOR CLINICAL STUDY; MONOTHERAPY; NONHUMAN; NS5A GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPLICON; SITE DIRECTED MUTAGENESIS; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; HEPACIVIRUS; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN STRUCTURE, TERTIARY; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 33747178354     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2006.00739.x     Document Type: Article

References (42)

1. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36(5 Suppl 1): S21-S29.
2. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347(13): 975-982.
3. Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358(9286): 958-965.
4. Watanabe H, Nagayama K, Enomoto N et al. Sequence elements correlating with circulating viral load in genotype 1b hepatitis C virus infection. Virology 2003; 311(2): 376-383.
5. Enomoto N, Sakuma I, Asahina Y et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995; 96(1): 224-230.
6. Enomoto N, Sakuma I, Asahina Y et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334(2): 77-81.
7. Kurosaki M, Enomoto N, Murakami T et al. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. Hepatology 1997; 25(3): 750-753.
8. Murakami T, Enomoto N, Kurosaki M et al. Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection: Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. Hepatology 1999; 30(4): 1045-1053.
9. Gerotto M, Dal Pero F, Pontisso P, Noventa F, Gatta A, Alberti A. Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon. Gastroenterology 2000; 119(6): 1649-1655.
10. Witherell GW, Beineke P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J Med Virol 2001; 63(1): 8-16.
11. Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001; 75(15): 7059-7066.
12. Majumder M, Ghosh AK, Steele R et al. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology 2002; 294(1): 94-105.
13. Tan SL, Nakao H, He Y et al. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 1999; 96(10): 5533-5538.
14. Arima N, Kao CY, Licht T, Padmanabhan R, Sasaguri Y. Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. J Biol Chem 2001; 276(16): 12675-12684.
15. Ghosh AK, Majumder M, Steele R et al. Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP. J Biol Chem 2000; 275(10): 7184-7188.
16. Zech B, Kurtenbach A, Krieger N et al. Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein. J Gen Virol 2003; 84(Pt 3): 555-560.
17. Ghosh AK, Majumder M, Steele R, Meyer K, Ray R, Ray RB. Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death. Virus Res 2000; 67(2): 173-178.
18. Lan KH, Sheu ML, Hwang SJ et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 2002; 21(31): 4801-4811.
19. Polyak SJ, Khabar KS, Paschal DM et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 2001; 75(13): 6095-6106.
20. Chung KM, Lee J, Kim JE et al. Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3. J Virol 2000; 74(11): 5233-5241.
21. Gale M Jr, Blakely CM, Kwieciszewski B et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 1998; 18(9): 5208-5218.
22. Gale MJ Jr, Korth MJ, Katze MG. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clin Diagn Virol 1998; 10(2-3): 157-162.
23. Ezelle HJ, Balachandran S, Sicheri F, Polyak SJ, Barber GN. Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A. Virology 2001; 281(1): 124-137.
24. Podevin P, Sabile A, Gajardo R et al. Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner. Hepatology 2001; 33(6): 1503-1511.
25. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285(5424): 110-113.
26. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290(5498): 1972-1974.
27. Bukh J, Pietschmann T, Lohmann V et al. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci U S A 2002; 99(22): 14416-14421.
28. Bartenschlager R, Lohmann V. Novel cell culture systems for the hepatitis C virus. Antiviral Res 2001; 52(1): 1-17.
29. Evans MJ, Rice CM, Goff SP. Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci USA 2004; 101(35): 13038-13043.
30. Gao L, Aizaki H, He JW, Lai MM. Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol 2004; 78(7): 3480-3488.
31. Tanji Y, Kaneko T, Satoh S, Shimotohno K. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol 1995; 69(7): 3980-3986.
32. Ikeda M, Yi M, Li K, Lemon SM. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 2002; 76(6): 2997-3006.
33. Maekawa S, Enomoto N, Sakamoto N et al. Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells. J Viral Hepat 2004; 11(5): 394-403.
34. Watanabe H, Enomoto N, Nagayama K et al. Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection. J Infect Dis 2001; 183(8): 1195-1203.
35. Guo JT, Bichko VV, Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J Virol 2001; 75(18): 8516-8523.
36. Yanagi M, St Claire M, Shapiro M, Emerson SU, Purcell RH, Bukh J. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology 1998; 244(1): 161-172.
37. Neddermann P, Quintavalle M, Di Pietro C et al. Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture. J Virol 2004; 78(23): 13306-13314.
38. Tu H, Gao L, Shi ST et al. Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology 1999; 263(1): 30-41.
39. Pietschmann T, Koutsoudakis G, Kallis S et al. Chimeric Hepatitis C Virus Infections in Cell Culture. Heidelberg, Germany: 11th International Symposium on Hepatitis C Virus and Related Viruses, 5-10 October, 2004.
40. Rosen HR. Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury. Liver Transpl 2003; 9(11): S35-S43.
41. Doyle S, Vaidya S, O'Connell R et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002; 17(3): 251-263.
42. Kanazawa N, Kurosaki M, Sakamoto N et al. Regulation of hepatitis C virus replication by interferon regulatory factor 1. J Virol 2004; 78(18): 9713-9720.